Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) Operating Expenses (2017 - 2025)

Catheter Precision has reported Operating Expenses over the past 9 years, most recently at $10.1 million for Q4 2025.

  • Quarterly Operating Expenses rose 216.06% to $10.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.9 million through Dec 2025, up 88.44% year-over-year, with the annual reading at $21.9 million for FY2025, 88.44% up from the prior year.
  • Operating Expenses was $10.1 million for Q4 2025 at Catheter Precision, up from $3.2 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $66.6 million in Q1 2023 and troughed at $2.7 million in Q1 2024.
  • The 5-year median for Operating Expenses is $5.2 million (2022), against an average of $8.4 million.
  • Year-over-year, Operating Expenses soared 1128.71% in 2023 and then crashed 95.95% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $7.9 million in 2021, then rose by 3.7% to $8.2 million in 2022, then crashed by 66.91% to $2.7 million in 2023, then rose by 17.33% to $3.2 million in 2024, then surged by 216.06% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Operating Expenses are $10.1 million (Q4 2025), $3.2 million (Q3 2025), and $4.9 million (Q2 2025).